Craig A. Collard, Director at OPIANT PHARMACEUTICALS, INC. (OPNT), bought 5,700 shares at $10.94 ($63K) on 2022-06-13, disclosed to the SEC on 2022-06-13.
Open-market purchase of $63k OPNT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.50 | 1,663 | $19K | 30.2% |
| 2 | $10.94 | 4,037 | $44K | 69.8% |
| Total | $11.10 avg | 5,700 | $63K | 100% |
| Filing → |
| OPNT | BUY | 2022-05-16 | $39K | — | Filing → |
| SRRA | BUY | 2021-11-24 | $622K | — | Filing → |
| OPNT | BUY | 2021-09-15 | $45K | — | Filing → |